Trends in Cardiovascular Medicine
Volume 19, Issue 5 , Pages 158-164, July 2009

Aldehyde Dehydrogenase 2 in Cardiac Protection: A New Therapeutic Target?☆

  • Grant R. Budas
    • ,
  • Marie-Hélène Disatnik
    • ,
  • Daria Mochly-Rosen

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Daria Mochly-Rosen, PhD, Department of Chemical and Systems Biology, Stanford University School of Medicine, CCSR, Rm 3145A, 269 Campus Drive, Stanford, CA 94305-5174, USA. Tel.: (+1) 650-725-7720

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305-5174, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by NIAA11147 to DMR and in part, by an American Heart Association postdoctoral fellowship to GRB.

PII: S1050-1738(09)00145-5

doi:10.1016/j.tcm.2009.09.003

Trends in Cardiovascular Medicine
Volume 19, Issue 5 , Pages 158-164, July 2009

Article Tools

* Image Usage & Resolution